Bank of America’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1
Closed -$31 6189
2025
Q4
$31 Hold
1
﹤0.01% 7045
2025
Q3
$121 Hold
1
﹤0.01% 7817
2025
Q2
$154 Buy
+1
New +$305 ﹤0.01% 7888
2025
Q1
Hold
0
7797
2024
Q4
Hold
0
7442
2024
Q3
Hold
0
7621
2024
Q2
Hold
0
7267
2024
Q1
Hold
0
7178
2023
Q4
Hold
0
7510
2023
Q3
Hold
0
6937
2023
Q2
Sell
-1
Closed -$37.2K 6708
2023
Q1
$23.4K Buy
+1
New +$56.4K ﹤0.01% 6724
2022
Q4
Hold
0
6977
2022
Q3
Hold
0
6949
2022
Q2
Hold
0
8151
2022
Q1
Hold
0
8041
2021
Q4
Hold
0
7829
2021
Q3
Sell
-1
Closed -$129K 7106
2021
Q2
$136K Buy
+1
New +$164K ﹤0.01% 6333
2021
Q1
Hold
0
6437
2020
Q4
Hold
0
6485
2020
Q3
Sell
-1
Closed -$158K 6502
2020
Q2
$72K Buy
+1
New +$122K ﹤0.01% 5819
2020
Q1
Hold
0
6985
2019
Q4
Hold
0
6882
2019
Q3
Hold
0
-$1K 7338
2019
Q2
Hold
0
7029

Other funds holding GNPX

Bank of America's GNPX Position: Q1 2026 in Review

Bank of America sold out of Genprex (GNPX) in Q1 2026, closing a stake of 1 share — an estimated $31 sold.

Bank of America first reported a position in GNPX in Q2 2020 and held it in 6 quarters. The position peaked at $136K in Q2 2021. 15 funds tracked by Wall St. Rank hold GNPX as of Q1 2026.

  • Bank of America reported no remaining Genprex position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 1 Genprex share in Q1 2026, an estimated $31.
  • Bank of America first reported a position in Genprex in Q2 2020 and held it in 6 quarters.
  • Bank of America's Genprex position peaked at $136K in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Genprex as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.